Invivoscribe (NASDAQ: VSCP) Launches PrepQuant™ Integrated Sample Preparation System

April 15, 2026

Key Developments Invivoscribe (NASDAQ: VSCP) has unveiled its PrepQuant™ system, an innovative integrated platform designed to streamline and standardize sample preparation workflows prior to molecular analysis. This automated device combines nucleic acid extraction, concentration, and quantification in a single solution, targeting improvements in cost efficiency and consistency for molecular testing. Developed in collaboration with Hitachi High-Tech Corporation, the PrepQuant system leverages Invivoscribe’s expertise in standardized molecular diagnostics and global clinical…

Read More >>